🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy

RecruitingNAAges 18 Years - anyMaleSir Mortimer B. Davis - Jewish General Hospital
NCT06521710 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients undergoing standard of care robotic radical prostatectomy for high-risk localized prostate cancer as defined by any of: 1. Gleason grade ≥8 2. PSA ≥20 3. \>pT2 on preoperative MRI imaging 2. Patients must have preoperative erectile function with a baseline IIEF score of ≥17 Exclusion Criteria: 1. Patients with previous pelvic surgery 2. Patients with previous pelvic radiotherapy 3. Patient with previous focal therapy for prostate cancer 4. Patients aged \< 18 years at diagnosis 5. Legally incapable patients 6. Patients who are unable to complete questionnaires and have no companion to help complete them 7. Patients undergoing a concomitant cancer surgery 8. Patients with pre-existing neurologic disease
💊

What it tests

  • Intraoperative Somatic-Autonomic Nerve Grafting
📍

Where

2 sites
Jewish General Hospital, CIUSSS Centre-Ouest de l&#39;île de Montréal
Montreal, Canada
Jewish General Hospital
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy